NEW YORK (Reuters Health) – Guselkumab may be effective in patients who have psoriatic arthritis with axial symptoms, a post-hoc analysis of data from two randomized controlled trials suggests. “Because psoriatic arthritis is a heterogeneous disease that manifests as various symptoms, treatment choices should involve consideration of all relevant domains of disease for each individual